Minamestane
Minamestane
Minamestane (pronounced: mi-na-mes-tane) is a steroidal aromatase inhibitor that is used in the treatment of breast cancer. It is also known as its developmental code name, FCE-24304.
Etymology
The term "Minamestane" is derived from the chemical structure of the drug, which is a steroidal aromatase inhibitor. The prefix "Mina" is derived from the Latin word 'minima', meaning 'the smallest', and "mestane" is a common suffix used in the names of steroidal aromatase inhibitors.
Usage
Minamestane is used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens to estrogens in the body. By inhibiting this enzyme, Minamestane reduces the levels of estrogen in the body, which can slow the growth of certain types of breast cancers that need estrogen to grow.
Related Terms
- Aromatase inhibitor: A class of drugs that inhibit the enzyme aromatase, which is responsible for the conversion of androgens to estrogens in the body.
- Breast cancer: A type of cancer that forms in the cells of the breasts.
- Steroidal aromatase inhibitor: A type of aromatase inhibitor that is structurally similar to the substrate of the enzyme it inhibits.
- FCE-24304: The developmental code name for Minamestane.
See Also
- List of aromatase inhibitors
- List of steroidal aromatase inhibitors
- List of breast cancer medications
External links
- Medical encyclopedia article on Minamestane
- Wikipedia's article - Minamestane
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski